Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China
2016
Background
Human papillomavirus (HPV) 16 and 18 are the two most common HPV oncogenic types that can be prevented by vaccination. This study aimed at assessing the cost-effectiveness of 3 doses of the bivalent HPV vaccine in rural and urban settings in China.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
71
References
6
Citations
NaN
KQI